It looks like Actemra by Roche, another anti-IL6 m
Post# of 148282
Patterson did mention that he believes that Leronlimab modulates IL-6, TNF and T suppressor so the clinical response maybe more powerful than drugs just targeting one of these molecules. This is where Ohm maybe able to do more DD for us.